|
DIAPH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.125700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.010500E-02 |
| Normal-vs-Stage2 |
4.030800E-01 |
| Normal-vs-Stage3 |
1.381160E-01 |
| Normal-vs-Stage4 |
9.802800E-01 |
| Stage1-vs-Stage2 |
9.724000E-01 |
| Stage1-vs-Stage3 |
6.823400E-01 |
| Stage1-vs-Stage4 |
4.972800E-01 |
| Stage2-vs-Stage3 |
7.442400E-01 |
| Stage2-vs-Stage4 |
5.507000E-01 |
| Stage3-vs-Stage4 |
3.489400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.546240E-01 |
| Normal-vs-AfricanAmerican |
4.374300E-02 |
| Normal-vs-Asian |
5.801000E-01 |
| Caucasian-vs-AfricanAmerican |
2.952800E-01 |
| Caucasian-vs-Asian |
7.348000E-01 |
| AfricanAmerican-vs-Asian |
9.794400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.548200E-02 |
| Normal-vs-Female |
2.867200E-01 |
| Male-vs-Female |
6.123200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.031600E-01 |
| Normal-vs-Extreme_Weight |
1.000620E-01 |
| Normal-vs-Obese |
1.376160E-01 |
| Normal-vs-Extreme_Obese |
4.991800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.811790E-01 |
| Normal_Weight-vs-Obese |
2.017800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.578200E-01 |
| Extreme_Weight-vs-Obese |
9.440800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.543800E-01 |
| Obese-vs-Extreme_Obese |
9.816600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.216300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.164070E-03 |
| Normal-vs-Age(61-80Yrs) |
9.444000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.063200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.058600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.959800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.965780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.605300E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.645000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.808600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.154100E-02 |
| Normal-VS-Type2 PRCC |
8.634300E-02 |
| Normal-VS-KIRP CIMP |
3.961200E-01 |
| Normal-VS-Unclassified PRCC |
8.716800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.816800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.975200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.335000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.947400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.086200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.432400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.574000E-01 |
| Normal-vs-N1 |
3.178200E-01 |
| Normal-vs-N2 |
6.994400E-01 |
| N0-vs-N1 |
5.902800E-01 |
| N0-vs-N2 |
7.587600E-01 |
| N1-vs-N2 |
9.507000E-01 |
|
|
